CRDL
Cardiol TherapeuticsDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
CRDL vs peer average
50/100
CRDL vs. peer average (D vs. D)
Grade spread
A 2 · D 3 · F 6
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
MXCT is the first available peer comparator.
Another loose life-sciences peer in a similar valuation range; relevant mainly for small-cap biotech risk appetite rather than direct cardiology-program comparability.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
CRDL
Cardiol Therapeutics
MXCT
MaxCyte
Grade
D
F
Momentum
91
19
Value
41
41
Sentiment
47
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs MXCT
CRDL / MXCT
Grade Position
In line
CRDL vs. peer average (D vs. D)
50/100
Momentum
91
CRDLValue
41
CRDLSentiment
47
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs CRDL
MXCT is the first peer returned for this comparison set.